Article

Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic target

2023-06-09

Abstract excerpt

<title>Abstract</title> <p>Relapsed prostate cancer (CaP), usually treated with androgen deprivation therapy, acquires resistance to develop into lethal metastatic castration-resistant CaP. The cause of resistance remains elusive, and the lack of biomarkers predictive of castration-resistance emergence is a stumbling block in managing the disease. We provide strong evidence that Myeloid differentiation factor-2 (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2d2b947b-e4b1-51a2-acce-1622dda5d6f4
DOI: 10.21203/rs.3.rs-2968406/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic targetDOI 10.21203/rs.3.rs-2968406/v1Read

GATA2 as a potential metastasis-driving gene in prostate cancerSemantic proximity Read

Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approachesSemantic proximity Read

Candidate biomarkers and gene modules investigation for bone tumor samples derived from castration-resistant prostate cancer bone metastasis patients using WGCNASemantic proximity Read

Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer ProgressionSemantic proximity Read

Identification of Key Gene Signatures Associated With Bone Metastasis in Castration-Resistant Prostate Cancer Using Co-Expression AnalysisSemantic proximity Read

SETD1A Promotes Proliferation of Castration-Resistant Prostate Cancer Cells via FOXM1 TranscriptionSemantic proximity Read

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expressionSemantic proximity Read

Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐CSemantic proximity Read

Correlation between high ratio of circulating PMN-MDSCs and poor prognosis in metastatic hormone sensitive prostate cancerSemantic proximity Read

Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.Semantic proximity Read

WITHDRAWN: GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunitySemantic proximity Read

Prognostic signatures associated with high infiltration of Tregs in bone metastatic prostate cancerSemantic proximity Read